LifeMD (NASDAQ:LFMD) reported second-quarter revenue of $47.3 million, within its prior guidance range, while posting an ...
Nyxoah (NASDAQ:NYXH) reported second-quarter worldwide net revenue of €7.7 million, up 21% sequentially from the first ...
Braveheart is one of five biotechnology firms that made plans to price an IPO this week, bringing in total what could ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results